Clinical Trials in Philadelphia

Showing 8941-8960 of 20,904 trials

Assessing the Impact of a Financial Navigation Program for Patients With Multiple Myeloma

NCT05448196

The study is a randomized controlled trial to develop and evaluate a coordinated financial navigation program at the Abramson Cancer Center (ACC) for patients with multiple myeloma and identify barriers to its broader implementation.

Multiple Myeloma

Abramson Cancer Center at Penn Medicine103 participantsStarted Mar 2022

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma

NCT01327885

This is a randomized, open-label, multicenter, Phase 3 study comparing the efficacy and safety of eribulin with dacarbazine in subjects with advanced soft tissue sarcoma who have disease progression within 6 months prior to study enrolment following standard therapies which must have included an anthracycline, unless contraindicated and then at least one additional regimen after failure of the anthracycline.

Soft Tissue Sarcoma

Eisai Inc.452 participantsStarted Mar 2011

Tucson, Arizona, United States • Los Angeles, California, United States • Orange, California, United States +116 more locations

Assessing the Impact of a Financial Navigation Program for Patients With Multiple Myeloma

Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma

Find Trials by Condition in Philadelphia

Chronic HBV Management for Asian American

Long-term Follow-up of Subjects Exposed to Lentiviral-based CART-EGFRvIII Gene-modified Cellular Therapy Products in Cancer Studies

Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Autologous T Cells Redirected to EGFRVIII-With a Chimeric Antigen Receptor in Patients With EGFRVIII+ Glioblastoma

CART-19 for Multiple Myeloma

Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer

Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCR and 4-1BB Signaling Domains in Patients With Chemotherapy Resistant or Refractory Acute Lymphoblastic Leukemia

Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer

ClearSight Validation in Pediatrics

BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease

Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression

Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma

Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.

Venous Sinus Stenting With the River Stent in IIH

Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study)

A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer

The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis